Aspen Pharmacare has reached a preliminary agreement with Johnson & Johnson to manufacture the US company’s Covid-19 vaccine should its clinical trials prove successful. The production will be done at Aspen’s Port Elizabeth facility. Business Day TV spoke to CEO Stephen Saad for more detail on the agreement.